Use of adoptive transfer of T-cell-antigen-receptor-transgenic T cell for the study of T-cell activation in vivo

Immunological Reviews
K A PapeMarc K Jenkins

Abstract

Adoptive transfer of TCR-transgenic T cells uniformly expressing an identifiable TCR of known peptide/MHC specificity can be used to monitor the in vivo behavior of antigen-specific T cells. We have used this system to show that naive T cells are initially activated within the T-cell zones of secondary lymphoid tissue to proliferate in a B7-dependent manner. If adjuvants or inflammatory cytokines are present during this period, enhanced numbers of T cells accumulate, migrate into B-cell-rich follicles, and acquire the capacity to produce IFN-gamma and help B cells produce IgG2a. If inflammation is absent, most of the initially activated antigen-specific T cells disappear without entering the follicles, and the survivors are poor producers of IL-2 and IFN-gamma. Our results indicate that inflammatory mediators play a key role in regulating the anatomic location, clonal expansion, survival and lymphokine production potential of antigen-stimulated T cells in vivo.

References

Oct 1, 1992·The Journal of Experimental Medicine·C P LarsenR P Lowry
Nov 13, 1992·Science·E J Fuchs, P Matzinger
Apr 11, 1991·International Immunology·Y Liu, C A Janeway
Oct 1, 1990·The Journal of Experimental Medicine·Y Kawabe, A Ochi
Feb 1, 1987·The Journal of Experimental Medicine·S L KoideR M Steinman
Apr 7, 1995·Science·M G McHeyzer-Williams, M M Davis
Oct 1, 1995·The Journal of Experimental Medicine·M M EpsteinP Matzinger
Jan 28, 1994·Cell·W E Paul, R A Seder
Jun 1, 1994·Journal of Leukocyte Biology·A Mondino, M K Jenkins
Mar 1, 1994·Stem Cells·S F WolfJ Sypek
Jan 1, 1993·Advances in Experimental Medicine and Biology·J G TewA Szakal
Jan 23, 1996·Proceedings of the National Academy of Sciences of the United States of America·A T VellaP Marrack
Jun 1, 1996·European Journal of Immunology·A D McLellanD N Hart
Jan 1, 1996·Annual Review of Immunology·D J LenschowJ A Bluestone
Aug 1, 1996·European Journal of Immunology·A Gulbranson-Judge, I MacLennan
Oct 1, 1996·The Journal of Experimental Medicine·T De SmedtM Moser

❮ Previous
Next ❯

Citations

Nov 28, 2000·European Journal of Immunology·A HamannD Jablonski-Westrich
Mar 10, 2001·European Journal of Immunology·A J MigaR J Noelle
Feb 10, 2000·Springer Seminars in Immunopathology·T Biedermann, M Röcken
Feb 14, 2004·Cellular Immunology·Roopjeet Kahlon, Jan P Dutz
Jul 2, 2005·Journal of Immunological Methods·Angela M GriersonPaul Garside
Apr 11, 2003·Molecular Immunology·Wesley P ThayerPeter E Jensen
Nov 30, 2000·Immunology Today·D Balomenos, C Martínez-A
Jul 19, 2000·Current Opinion in Immunology·V E Schijns
May 7, 2002·Allergy·D von BubnoffT Bieber
Jul 9, 2011·Nature Immunology·Marion Pepper, Marc K Jenkins
Apr 19, 2005·Nature Immunology·Meredith SaffordJonathan D Powell
Apr 18, 2009·Nature Protocols·James J MoonMarc K Jenkins
Oct 6, 2007·Nature Reviews. Immunology·Margaret M Harnett
Jun 8, 1999·The Journal of Experimental Medicine·H XieA H Lichtman
Nov 2, 1999·The Journal of Experimental Medicine·L LefrançoisD Masopust
Nov 2, 1999·The Journal of Experimental Medicine·L CohnK Bottomly
Feb 16, 2005·The Journal of Experimental Medicine·Cécile BouneaudChristophe Pannetier
Oct 7, 2006·Current Opinion in Gastroenterology·A M Mowat
Jul 13, 1999·Transplantation·J A BarbaraK J Wood
Jun 3, 2000·Annual Review of Immunology·J BanchereauK Palucka
Mar 13, 2001·Annual Review of Immunology·M K JenkinsK A Pape
Oct 13, 2000·American Journal of Respiratory and Critical Care Medicine·K M SmithP Garside
Jul 4, 2009·American Journal of Respiratory Cell and Molecular Biology·Barbro N MelgertAnuradha Ray
Jun 3, 2005·The Journal of Clinical Investigation·Daniel E Speiser, Pedro Romero
Oct 25, 2012·PLoS Pathogens·Somedutta BaratDirk Bumann
Nov 28, 2002·Proceedings of the National Academy of Sciences of the United States of America·Michael J PinkoskiDouglas R Green
Aug 2, 2006·Proceedings of the National Academy of Sciences of the United States of America·Nadia R RoanMichael N Starnbach
Jul 19, 2000·Proceedings of the National Academy of Sciences of the United States of America·V AttuilJ L Maryanski

❮ Previous
Next ❯

Related Concepts

Related Feeds

Avian Influenza: Innate Immune Adjuvant

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.

Avian Influenza: Innate Immune Adjuvant (ASM)

Adjuvants systems that are added to vaccines against avian influenza have be explored to enhance the innate immune system response against the virus. Here is the latest research on avian influenza and the innate immune adjuvant.